While this combination did not enhance the production of IFN-gamma by CD8+ T cells in tumor-bearing mice beyond that of PD-L1 antibody alone (not shown), regression of uninjected bystander B16 tumor was measured, supporting the induction of a robust systemic anti-tumor response. This evidence concerns the gene CD8A and neoplasm.